IV-Globulin SN Inj.10%

intravenous immunoglobulin · Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IV-Globulin SN Inj.10%, covering 2016-05-25 to 2016-05-25. Get the full timeline:

Most recent: Clinical Trial Update: An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia [Phase 3]